Innovation and Technology Payment

Delivered in partnership with the Academic Health Science Networks, the Innovation and Technology Payment (ITP) programme supports NHS England’s commitment to accelerate the adoption and spread of proven and affordable innovations, as set out in the Five Year Forward View and NHS Long Term Plan.

The ITP aims to remove financial and procurement barriers to support the NHS to adopt innovative medical devices, diagnostics, and digital products. The ITP builds on the Innovation and Technology Tariff (ITT), ITP 2018/19 and has product crossover with recommendations from the Accelerated Access Collaborative.

Each innovation has been proven to be:

  • Safe – avoiding harm to patients wherever possible
  • Effective – providing support based on clear benefit to patients
  • Efficient – avoiding waste
  • Person-centred – accepting patient’s needs and preferences
  • Timely – reducing waits and harmful delays
  • Equitable – care does not vary in quality due to patient characteristics

The programme forms part of a wider set of activities to support innovation in the NHS, led by NHS England in partnership with the AHSN Network.

This year we are excited to support innovations transforming care, including:

  • Faster and better mental health assessments via app-based tech
  • Improved heart attack pathways for faster, more appropriate care
  • Non-invasive treatment for cluster headaches
  • Improved diagnostic tools for pre-eclampsia detection

To see the full list of innovations, please click here.

Examples of products on the 2019/20 ITP

S12 Solutions

Better care is needed for vulnerable, at-risk individuals as part of the Mental Health Act. S12 Solutions connects Approved Mental Health Practitioners (AMHPs) with available local S12 doctors via an app and website, helping to reduce assessment delays caused by the current paper-based assessment set-up process. It reduces distress and risk for vulnerable individuals, gives doctors and AMHPs better control over their s.12 work and reduces the risk of unlawful detention. S12 Solutions is part of the Evidence Generation Fund (EGF), a subset of ITP, with funding still available and a more in-depth evaluation during 2019-2020. This innovation is also part of the NHS Innovation Accelerator, read more here.

High-Sensitivity Troponin

High sensitivity troponin assays have been developed to detect lower levels of troponin in the blood earlier than older standard assays, leading to improved early detection of acute heart attacks. This innovation will allow suspected heart attack patients presenting at emergency departments (ED) to be identified as early as possible for effective treatment, reduced wait for care and quicker discharge from the ED. Read more here.

Placental growth factor (PlGF)

PlGF-based testing can be used with clinical judgement and other diagnostic tests to help diagnose suspected pre-eclampsia. Pre-eclampsia is a condition that affects some pregnant women, usually during the second half of pregnancy. It causes high blood pressure and protein in the urine and, if not diagnosed and closely monitored, it can lead to potentially life-threatening complications. Using this innovation will allow for accurate diagnosis and treatment and reduce unnecessary hospital stays. Read more here.

We need people in the South West to be part of this transformative care. If you work in health and social care and would like to understand how these innovations could help your patients, please contact info@swahsn.com